Immuron Completes Phase II NASH Clinical Trial Recruitment
20. Februar 2017 09:59 ET
|
Immuron Limited
MELBOURNE, Australia, Feb. 20, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC), an Australian biopharmaceutical company focused on oral immunotherapy utilizing polyclonal antibody products to...
Immuron Initiates NASH MOA Studies with SanyalBio and with Duke University
19. Januar 2017 10:00 ET
|
Immuron Limited
MELBOURNE, Australia, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Australian biopharmaceutical Company Immuron Limited (ASX:IMC) is pleased to announce the initiation of several studies designed to add to the...
European/US Analyst: Immuron Moving to Forefront in NASH
18. Januar 2017 15:02 ET
|
Immuron Limited
MELBOURNE, Australia, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (the “Company”) wishes to advise investors that European and US-based Life Sciences Research and Analyst firm Van...
NASH Transactions by JNJ, BMS and Novartis, Highlight Continued Appetite for NASH Assets
06. Januar 2017 09:30 ET
|
Immuron Limited
MELBOURNE, Australia, Jan. 06, 2017 (GLOBE NEWSWIRE) -- Following the US$1.7B proposed takeover of Tobira by Allergan, three more Licensing Mergers & Acquisitions (LM&A) transactions over...
Enjoy Your Holiday Travel and Protect Yourself from Food-Borne Illness with Travelan
22. Dezember 2016 14:56 ET
|
Immuron Limited
FARMINGTON, Conn., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Immuron Limited: The latest travel forecast released this week by AAA, projects that 103 million Americans will travel during the December 23,...
Immuron Files F-1 with the SEC
21. Dezember 2016 21:00 ET
|
Immuron Limited
MELBOURNE, Australia, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Australian biopharmaceutical Company, Immuron Limited (ASX:IMC), is pleased to announce today that it filed its Registration Statement on Form...
Immuron Receives $1.59M R&D Tax Concession Refund
29. November 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) is pleased to announce that under the Australian Government’s Research and Development Income Tax Concession...
Protect Yourself from Contaminated Food During the 2016 Holiday Travel Season with Travelan
21. November 2016 15:11 ET
|
Immuron Limited
FARMINGTON, Conn., Nov. 21, 2016 (GLOBE NEWSWIRE) -- Immuron Limited: According to AAA research released this week, 48.7 million Americans are expected to travel within the U.S. this...
Immuron Announces Availability of RedChip Conference Presentation
25. Juli 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, July 25, 2016 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (OTCQB:IMROY) announces the availability of its presentation from RedChip’s Small Stocks, Big Money Investor...
Immuron to Cooperate with Leading Australian Universities on Autism Research
20. Juli 2016 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, July 20, 2016 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company, Immuron Limited (ASX:IMC) (OTCQB:IMROY), today announced it has formed a strategic...